| Dec'17 | Dec'16 | Dec'15 | ||||
|---|---|---|---|---|---|---|
NET REVENUES | ||||||
4,007 | 101 | 3 | ||||
COST OF REVENUES | ||||||
2,126 | - | - | ||||
GROSS PROFIT | ||||||
1,881 | 101 | 3 | ||||
RESEARCH AND DEVELOPMENT EXPENSES, net | ||||||
32,969 | 25,241 | 17,771 | ||||
SELLING, MARKETING AND BUSINESS DEVELOPMENT EXPENSES | ||||||
12,014 | 1,555 | 1,386 | ||||
GENERAL AND ADMINISTRATIVE EXPENSES | ||||||
8,025 | 3,848 | 2,748 | ||||
OTHER EXPENSES | ||||||
-845 | - | -100 | ||||
OPERATING LOSS | ||||||
-51,972 | -30,543 | -22,002 | ||||
FINANCIAL INCOME | ||||||
6,505 | 1,548 | 1,124 | ||||
FINANCIAL EXPENSES | ||||||
77 | 375 | 212 | ||||
FINANCIAL INCOME (EXPENSES), net | ||||||
6,428 | 1,173 | 912 | ||||
LOSS AND COMPREHENSIVE LOSS FOR THE PERIOD | ||||||
-45,544 | -29,370 | -21,090 | ||||
LOSS PER ORDINARY SHARE (U.S. dollars): | ||||||
Basic (in dollars per share) | ||||||
-0.26 | -0.23 | -0.19 | ||||
Diluted (U.S. dollars) | ||||||
-0.26 | -0.24 | -0.19 | ||||